CWM
RCUS icon

CIBC World Markets’s Arcus Biosciences RCUS Stock Holding History

CIBC World Markets’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,065
Closed -$94.7K – 1853
2025
Q1 		$94.7K Buy
+12,065
New +$140K ﹤0.01% 1613

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CIBC World Markets's RCUS Position: Q2 2025 in Review

CIBC World Markets sold out of Arcus Biosciences (RCUS) in Q2 2025, closing a stake of 12,065 shares — an estimated $94.7K sold.

CIBC World Markets first reported a position in RCUS in Q1 2025 and held it in 1 quarter. The position peaked at $94.7K in Q1 2025. 185 funds tracked by Wall St. Rank hold RCUS as of Q2 2025.

  • CIBC World Markets reported no remaining Arcus Biosciences position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 12,065 Arcus Biosciences shares in Q2 2025, an estimated $94.7K.
  • CIBC World Markets first reported a position in Arcus Biosciences in Q1 2025 and held it in 1 quarter.
  • CIBC World Markets's Arcus Biosciences position peaked at $94.7K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.